INDSWIFT LABORATORIES
Back to Income Statement
|
INDSWIFT LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹649 Cr | ₹574 Cr | ₹1,281 Cr | ₹1,207 Cr | ₹1,039 Cr |
What is the latest Revenue of INDSWIFT LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹649 Cr |
| Mar2025 | ₹574 Cr |
| Mar2024 | ₹1,281 Cr |
| Mar2023 | ₹1,207 Cr |
| Mar2022 | ₹1,039 Cr |
How is Revenue of INDSWIFT LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹649 Cr | 13.04 | |
| Mar2025 | ₹574 Cr | -55.17 | |
| Mar2024 | ₹1,281 Cr | 6.10 | |
| Mar2023 | ₹1,207 Cr | 16.23 | |
| Mar2022 | ₹1,039 Cr | - | |
Compare Revenue of peers of INDSWIFT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDSWIFT LABORATORIES | ₹3,201.8 Cr | 1.6% | 0.3% | 246.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹454,914.0 Cr | 3.9% | 7.8% | 13% | Stock Analytics | |
| DIVIS LABORATORIES | ₹300,380.0 Cr | 11.5% | 20.6% | 68% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,169.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,933.0 Cr | 1.1% | 11.8% | 14.9% | Stock Analytics | |
| CIPLA | ₹114,478.0 Cr | 1.1% | 7.9% | -6.3% | Stock Analytics | |
INDSWIFT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDSWIFT LABORATORIES | 1.6% |
0.3% |
246.2% |
| SENSEX | 5.9% |
13% |
-1.9% |
You may also like the below Video Courses